Study suggests supplement may reproduce elements of fasting biology in older adults with elevated HbA1c – without dietary restriction.
Fasting is arguably the most powerful metabolic stressor we have – a way to nudge cells into a state of repair, recycling and efficiency – but its practical appeal usually hits a wall somewhere between dinner and breakfast. Despite the mountain of data supporting calorie restriction, adherence remains the industry’s quietest obstacle. The reality is that most people simply don’t have the discipline to fast long enough, or consistently enough, to hit the metabolic signatures seen in a controlled lab setting.
Now new data from Mimio Health – a San Francisco-based startup specializing in fasting mimetics – comes from a randomized, double-blind, placebo-controlled trial of 42 overweight older adults [1]. This is a cohort already showing the early red flags of elevated HbA1c, and the company reports that its formulation, which is a patented blend of spermidine, nicotinamide, palmitoylethanolamide and oleoylethanolamide, managed to trigger several cardiometabolic shifts usually reserved for the fasted state, including reductions in LDL particle number (the individual ‘vehicles’ that transport cholesterol), oxidized LDL and fasting glucose. It’s an intriguing result: it suggests that by using a targeted ‘cocktail’ of metabolites, we can essentially trick the body into a fasting response without the actual deprivation.
The eight-week intervention demonstrates the biochemistry can be replicated in the short term, but the real test is the long game – whether these biomarker shifts can translate into durable metabolic resilience or if they are just temporary echoes of a complex biological process.
Longevity.Technology: Fasting has long occupied a mythic position in the field – a metabolic ‘reset’ capable of nudging cells toward repair and efficiency – but for most, it’s a practice they flirt with briefly before retreating to breakfast. The appeal of a fasting mimetic isn’t just novelty; it’s pure practicality. If you can replicate the beneficial signaling of nutrient deprivation without the monkish discipline, you move the intervention from a willpower test to everyday preventive biology. That is the promise Mimio is testing: an attempt to capture the ‘survival mode’ signals of a 36-hour fast without the behavioral burden that normally accompanies it. Though, as ever in geroscience, the real question is not whether biomarkers shift over eight weeks, but whether those shifts translate into durable improvements in metabolic resilience, disease risk and ultimately healthspan. In other words, if fasting is the orchestra of metabolic adaptation, mimetics are trying to play the same symphony using a handful of instruments – intriguing, potentially useful and certainly more convenient, but the field will need to see how closely the music actually matches the score.
To explore the science behind Mimio’s fasting mimetic formulation – and how closely a supplement can replicate the complex metabolic shifts seen during prolonged fasting – we sat down with Dr Chris Rhodes, CEO and scientific founder of Mimio Health.
From fasting biology to formulation
Rhodes kicks off by returning to the basic scientific question that originally motivated Mimio’s work – not whether fasting has biological benefits, but whether those benefits can be reproduced without the behavioral strain that typically accompanies caloric restriction.
“Fasting triggers a very complex metabolic state,” he says. “After around 36 hours without food the body shifts into a very specific biochemical profile – certain metabolites rise, others fall – and that pattern is what drives many of the downstream effects people associate with fasting.”
Rather than attempting to mimic the outward behavior of fasting, the Mimio team focused on the underlying metabolomic landscape. By analyzing the metabolic signatures produced during prolonged fasting, they sought to identify the compounds most closely associated with those physiological changes – and then reconstruct that biochemical environment nutritionally.
“Our hypothesis was that if we could supply the key metabolites that appear during fasting, we might be able to reproduce part of that biological state without requiring people to stop eating,” Rhodes explains. “In other words, instead of waiting for the body to generate those signals through deprivation, we provide them directly.”
Which parts of fasting can actually be mimicked
That approach raises an obvious question: how much of fasting biology can realistically be reproduced outside the context of actual caloric restriction?
Rhodes is careful not to suggest that a supplement can replicate the entire metabolic choreography of fasting. The physiological state triggered by prolonged food deprivation involves hundreds of interacting pathways – nutrient sensing, mitochondrial signaling, autophagy regulation and shifts in hormonal control among them.
“What we’re really trying to do is reproduce a subset of those signals,” he says. “Fasting activates pathways like AMPK, sirtuins and Nrf2 – systems that help regulate metabolism, oxidative stress and cellular maintenance. Our goal is to nudge those same pathways in a similar direction.”
That nuance matters. While the randomized trial reported improvements in markers linked to metabolic health – including LDL particle number, oxidized LDL and fasting glucose – Rhodes emphasizes that these are early indicators rather than definitive proof of long-term healthspan effects [1].
“We see this as a metabolic intervention,” he says. “The question is whether shifting those pathways in a fasting-like direction can support metabolic resilience over time.”
Testing the hypothesis in humans
The company’s recently reported trial was designed to explore exactly that possibility. Conducted as a randomized, double-blind, placebo-controlled study, the eight-week intervention enrolled overweight adults with elevated HbA1c – a group already showing signs of metabolic dysregulation [1].
For Rhodes, that population was deliberate. “These are individuals who are beginning to experience metabolic strain,” he notes. “If an intervention can improve markers in that context, it suggests the underlying biology is being meaningfully engaged.”
Participants continued their normal diets while taking the fasting mimetic formulation, allowing researchers to examine whether the supplement alone could reproduce some elements of fasting physiology.
“What was interesting,” Rhodes says, “was that we saw changes consistent with what you’d expect during fasting – shifts in lipid metabolism, reductions in oxidative stress markers and improvements in certain glucose parameters.”
Those results, he adds, align with earlier mechanistic research on fasting biology, but human evidence in this area remains relatively sparse. Controlled trials that examine fasting mimetics without requiring dietary restriction are still uncommon.
A practical route to fasting biology
Ultimately, the appeal of fasting mimetics may lie less in novelty than in feasibility. Sustained fasting regimens can be powerful experimental tools, but they are also demanding – particularly for older adults or people managing metabolic conditions.
Rhodes sees the emerging field as an attempt to translate the biology of fasting into something that fits more comfortably into everyday life.
“Most people are not going to fast for two or three days on a regular basis,” he says. “If we can capture some of the metabolic signaling associated with fasting in a way that is safe, controlled and easier to adopt, that opens the door to a very different kind of preventive intervention.”
Whether this translates into actual healthspan gains depends on the industry moving past eight-week windows and into much larger, longitudinal cohorts. This trial serves as a neat proof-of-concept for a much larger shift in geroscience: the realization that fasting’s benefits aren’t tethered to the hunger itself, but to the specific molecular signals that deprivation creates. If we can isolate that signal from the noise of the fast, we are no longer just skipping meals – we are engineering a metabolic state. The challenge now is to see if these biochemical echoes can be sustained over the long term, or if they require the actual stress of the fast to remain durable.
“Fasting has been studied for a long time because it reveals something fundamental about how metabolism responds to stress,” Rhodes says. “What we’re trying to understand is whether those signals can be harnessed in a more practical way.”
Fasting is a brutal but effective metabolic stress test; the challenge now is to prove that its biochemical echoes can be captured without the deprivation. If Mimio can truly replicate those 36-hour molecular signals in a pill, then we are no longer just asking people to skip breakfast – we are finally starting to treat metabolism as a system we can actually control.
Photographs courtesy of Mimio Health
